Covered recipient · General Payments record
RAYMOND CATANIA
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2020
$2,635.26
- Reported across 170 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2020 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $240.42 | 11 |
By paying entity
PY2020 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $131.90 | 3 |
| Amgen Inc. | $44.33 | 3 |
| Kowa Pharmaceuticals America, Inc. | $28.84 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $12.80 | 1 |
| Novo Nordisk AS | $11.54 | 1 |
| Janssen Pharmaceuticals, Inc | $11.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2020 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.76 | 02/21/2020 | Food and Beverage | Undisputed | 01/23/2026 | 741274079 | CMS |
| Amgen Inc. | $14.75 | 03/04/2020 | Food and Beverage | Undisputed | 01/23/2026 | 741274081 | CMS |
| Amgen Inc. | $14.82 | 03/11/2020 | Food and Beverage | Undisputed | 01/23/2026 | 741432427 | CMS |
| Janssen Pharmaceuticals, Inc | $11.01 | 01/15/2020 | Food and Beverage | Undisputed | 01/23/2026 | 719369951 | CMS |
| Kowa Pharmaceuticals America, Inc. | $14.99 | 01/17/2020 | Food and Beverage | Undisputed | 01/23/2026 | 716715887 | CMS |
| Kowa Pharmaceuticals America, Inc. | $13.85 | 02/14/2020 | Food and Beverage | Undisputed | 01/23/2026 | 716719573 | CMS |
| Novartis Pharmaceuticals Corporation | $12.80 | 02/12/2020 | Food and Beverage | Undisputed | 01/23/2026 | 725629395 | CMS |
| Novo Nordisk Inc | $11.54 | 01/29/2020 | Food and Beverage | Undisputed | 01/23/2026 | 745125835 | CMS |
| PFIZER INC. | $9.80 | 01/24/2020 | Food and Beverage | Undisputed | 01/23/2026 | 743326847 | CMS |
| PFIZER INC. | $8.90 | 02/05/2020 | Food and Beverage | Undisputed | 01/23/2026 | 743326841 | CMS |
| PFIZER INC. | $113.20 | 02/25/2020 | Food and Beverage | Undisputed | 01/23/2026 | 743114967 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020
- Generated from
- OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.